| Code | 3515D | ||||||||||
| MA number | 07/0025/20-S | ||||||||||
| Product Form: | cps mol 20x400 mg (blis.PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al transparent | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.02.2020 |
| Validity: | 04.02.2025 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ibuprofen Dr.Max 400 mg mäkké kapsuly_02.2024.pdf
|
| PIL: |
PIL_Ibuprofen Dr.Max 400 mg mäkké kapsuly_02.2024.pdf
|
| Safety feature | No |
| Data update: | 05.02.2020 |
